Peter Rhode - 08 Sep 2021 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role: Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations.
Signature: /s/ Nicole Valdivieso, as Attorney-in-Fact for Peter Rhode
Issuer symbol: HCWB
Transactions as of: 08 Sep 2021
Transactions value $: $0
Form type: 4
Filing time: 10 Sep 2021, 17:48:38 UTC
Previous filing: 23 Jul 2021
Next filing: 19 Jan 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCWB	Stock Option (Right to Buy)	Award	$0	+20K		$0.00	20K	08 Sep 2021	Common Stock	20K	$4.31	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.

Remarks:

Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations.